Cerebras Systems is navigating its sharpest two-week selloff since listing, down 20% on the week and 12% over the past month, arriving at $176.61 against a backdrop where the borrow market is finally loosening — a meaningful shift after weeks of extreme constraint.
The lending story has been the defining tension in CBRS positioning all month. Availability was completely exhausted from late June through early July, with zero shares available to borrow for six consecutive sessions through July 1. That changed fast. By July 3, a sliver of availability had returned at 2.1%; by July 7, it had widened to 11.3% — still tight, but no longer fully locked out. Cost to borrow has dropped sharply in parallel, falling 24% on the week to 3.2%, though that figure is still nearly triple its mid-June level of around 1%. Shares short have pulled back 6% over the week to 10.6 million, consistent with some unwinding as availability returned. The ORTEX short score remains elevated at 66.9, down modestly from 68.7 at the start of the week, reflecting a short base that is trimming but not retreating. Positioning looks like gradual unwind rather than a capitulation.
The earnings catalyst driving this week's move was severe. CBRS reported on June 23 and the stock fell 18.8% the next day — the largest one-day drop in its brief public history. The five-day move recovered most of that ground, ending just 1.5% lower, but the stock has since rolled back through those levels on renewed selling. A follow-on FINRA data point showed 8.1 million shares short as of the June 15 settlement date, with a days-to-cover of only 1.6 — suggesting short positions can be exited quickly if the stock rallies. The next earnings event is not until September 22, giving little near-term catalyst to force a resolution in either direction.
Options traders are not expressing much urgency here. The put/call ratio closed at 0.64 on July 7, essentially in line with its 20-day average of 0.62 and only 0.35 standard deviations above it — nowhere near the defensive extremes it reached in late May, when the PCR was running above 0.90. That means options positioning is neutral rather than skewed for protection, a contrast with the severe pressure visible in the stock price itself.
The Street remains broadly constructive despite the drawdown, though there is a notable gap between analyst conviction and current price action. Morgan Stanley lifted its target to $273 on June 24 and UBS pushed to $320, both after the stock printed above $220. Freedom Capital initiated at a Hold with a $209 target on June 30 — the sole dissenter from an otherwise bullish analyst cluster. The mean target across the coverage group sits around $291, implying roughly 65% upside from current levels, though those targets were set when the stock was materially higher. Bulls point to the AWS partnership and strong customer CapEx commitments as durable tailwinds. Bears focus on capacity constraints and the intense competitive pressure in AI compute. Valuation is complicated by a negative trailing PE, with the stock trading on a price-to-book of around 10x — not cheap for a company still burning cash.
The institutional register is dominated by early backers still holding large positions: FMR (Fidelity) holds 11.3% of shares, Foundation Capital 6.8%, and Benchmark 6.7% — all with last-reported changes showing fresh additions rather than exits. However, COO Dhiraj Mallick sold $2.1 million worth of stock on June 30, the largest single insider transaction in the recent register, joined by smaller sales from the Chief Accounting Officer. The net insider position over 90 days is modestly positive at roughly 30,000 shares net bought, but the recent direction of travel from named officers is clearly toward the exit.
With availability now back in the market after two weeks of complete lockout, the key question heading into the coming sessions is whether that returning supply absorbs the existing short base quietly — or triggers a fresh wave of positioning as newly available borrows attract new entrants.
See the live data behind this article on ORTEX.
Open CBRS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
